Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim—correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF
Crossref DOI link: https://doi.org/10.1007/s00520-016-3116-3
Published Online: 2016-02-10
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lehmacher, W.
Klasser, M.
Duering, A.
License valid from 2016-02-10